Ali Yilmaz

13PUBLICATIONS
13CO-AUTHORS
Gene and molecular therapyCardiology (incl. cardiovascular diseases)Cell physiologySensory processes, perception and performanceApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 27, 2025
CMR-based assessment of long-term effects of tafamidis in patients with cardiac transthyretin amyloidosis.

Alexandru Zlibut, Michael Bietenbeck, Nuriye Akyol

|Aug 19, 2025
Cardiac myosin inhibitors in hypertrophic cardiomyopathy: the need for precision medicine.

Ali Yilmaz

|Jun 13, 2024
Six-minute walk test as clinical end point in cardiomyopathy clinical trials, including ATTR-CM: a systematic literature review.

Jose Nativi-Nicolau, Ali Yilmaz, Noel Dasgupta

|Jun 06, 2022
Therapeutic value of tafamidis in patients with wild-type transthyretin amyloidosis (ATTRwt) with cardiomyopathy based on cardiovascular magnetic resonance (CMR) imaging.

Bishwas Chamling, Michael Bietenbeck, Dennis Korthals

|Mar 04, 2022
Sustained Impairment in Cardiopulmonary Exercise Capacity Testing in Patients after COVID-19: A Single Center Experience.

Georg Evers, Arik Bernard Schulze, Irina Osiaevi

|Jan 18, 2021
Diagnosis and treatment of cardiac amyloidosis: position statement of the German Cardiac Society (DGK).

A Yilmaz, J Bauersachs, F Bengel

Pageof 3

Frequent Collaborators

1 joint publications

Georg Evers

1 joint publications

Arik Bernard Schulze

1 joint publications

Irina Osiaevi

1 joint publications

Kimon Harmening